| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Kyverna Therapeutics, Inc. | Chief Technology Officer | Common Stock | 22,636 | $276,159 | $12.20 | 15 Dec 2025 | Direct |
| Kyverna Therapeutics, Inc. | Chief Technology Officer | Stock option (right to buy) | 85,865 | 15 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| KYTX | Kyverna Therapeutics, Inc. | 15 Dec 2025 | 3 | -$176,865 | 4 | Chief Technology Officer | 17 Dec 2025, 20:30 |
| KYTX | Kyverna Therapeutics, Inc. | 11 Apr 2025 | 2 | $0 | 4 | Chief Technology Officer | 15 Apr 2025, 17:40 |
| KYTX | Kyverna Therapeutics, Inc. | 06 Jun 2024 | 2 | +$42,591 | 4 | Chief Technology Officer | 10 Jun 2024, 18:56 |
| KYTX | Kyverna Therapeutics, Inc. | 07 Feb 2024 | 0 | $0 | 3 | Chief Technology Officer | 07 Feb 2024, 21:57 |